TCL Archive “Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate November 7, 1975
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010